<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Neuroscience</journal-title></journal-title-group><issn pub-type="ppub">1662-4548</issn><issn pub-type="epub">1662-453X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4935676</article-id><article-id pub-id-type="doi">10.3389/fnins.2016.00320</article-id><article-categories><subj-group subj-group-type="heading"><subject>Psychiatry</subject><subj-group><subject>Correction</subject></subj-group></subj-group></article-categories><title-group><article-title>Corrigendum: Commentary: Evaluation of Models of Parkinson's Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Paris</surname><given-names>Irmgard</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Segura-Aguilar</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/318600/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile</institution><country>Santiago, Chile</country></aff><aff id="aff2"><sup>2</sup><institution>Departamento de Ciencia B&#x000e1;sicas, Facultad de Ciencias, Universidad Santo Tomas</institution><country>Vi&#x000f1;a del Mar, Chile</country></aff><author-notes><fn fn-type="edited-by"><p>Edited and reviewed by: Mark R. Cookson, National Institutes of Health, USA</p></fn><corresp id="fn001">*Correspondence: Juan Segura-Aguilar <email xlink:type="simple">jsegura@med.uchile.cl</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>7</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>10</volume><elocation-id>320</elocation-id><history><date date-type="received"><day>16</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Mu&#x000f1;oz, Paris and Segura-Aguilar.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Mu&#x000f1;oz, Paris and Segura-Aguilar</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><related-article id="d36e126" related-article-type="corrected-article" xlink:href="27147953" ext-link-type="pubmed" journal-id="Front Neurosci" journal-id-type="nlm-ta" vol="10" page="161">A corrigendum on <article-title>Commentary: Evaluation of Models of Parkinson's Disease</article-title> by Mu&#x000f1;oz, P., Paris, I., and Segura-Aguilar, J. (2016). Front. Neurosci. 10:161. doi: <object-id>10.3389/fnins.2016.00161</object-id></related-article><kwd-group><kwd>dopamine o-quinone</kwd><kwd>dopamine</kwd><kwd>aminochrome</kwd><kwd>neurodegenration</kwd><kwd>astrocytes</kwd><kwd>dopaminergic neurons</kwd></kwd-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="0"/><page-count count="2"/><word-count count="368"/></counts></article-meta></front><body><p>It was an error in the structure of dopamine o-quinone published in the commentary on Evaluation of models of Parkinson's disease since the benzene ring contained an extra double bound between the carbonyls. The actual structure of dopamine o-quinone is the correct structure.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity</bold>. Astrocytes secrete GSTM2 which is internalized by dopaminergic neurons in order to increase their protection against aminochrome. Dopamine oxidation to neuromelanin is a harmless pathway due to the presence of DT-diaphorase and GSTM2 that prevent aminochrome-dependent neurotoxicity by inhibiting the formation of alpha-synuclein (SNCA) neurotoxic oligomers, mitochondrial dysfunction, oxidative stress, autophagy, and proteasome dysfunction and endoplasmic reticulum stress.</p></caption><graphic xlink:href="fnins-10-00320-g0001"/></fig><sec id="s1"><title>Author contributions</title><p>All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.</p></sec><sec id="s2"><title>Funding</title><p>Supported by University of Chile (ENL014/14).</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body></article>